Xiuyi Zhi

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Caicun Zhou, Yi‐Long Wu, Gongyan Chen et al. · The Lancet Oncology · 2011 · 4.1K citations

Medicine, Oncology, Pharmacology +10

Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry

Wenhua Liang, Jiaxi He, Yaxing Shen et al. · Journal of Clinical Oncology · 2017 · 358 citations · Full text

Medicine, Biostatistics, Oncology +17

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Johannes R. Kratz, Jianxing He, Stephen K. Van Den Eeden et al. · The Lancet · 2012 · 331 citations

Medicine, Molecular Biology, Oncology +15

Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.

Zhi Gao, Zhidong Xu, Ming‐Szu Hung et al. · PubMed · 2009 · 123 citations

Life Sciences, Molecular Biology, Oncology +15

Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test

Wenhua Liang, Zhiwei Chen, Caichen Li et al. · Journal of Clinical Investigation · 2021 · 115 citations · Full text

Medicine, Oncology, Radiology +14